Tenet Board Adds Two New Independent Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
UBS Reiterates Buy on Tenet Healthcare (THC) After Hosting Management Meetings
January 21, 2016 11:23 AM ESTUBS maintained a Buy rating on Tenet Healthcare (NYSE: THC), and cut the price target to $51.00 (from $62.00), after meeting with management. THC reiterated that it expects to show solid growth in 2016 relative to its pro-forma 2015 EBITDA run rate of $2.3 bln. Consensus expectations call for just under $2.5... More
Mizuho Securities Upgrades Tenet Healthcare (THC) to Outperform
January 19, 2016 8:48 AM ESTMizuho Securities upgraded Tenet Healthcare (NYSE: THC) from Neutral to Outperform with a price target of $30.00 as two Glenview partners join the board.
Analyst Sheryl R. Skolnick commented, "Glenview's two HC partners are joining THC's Board and the firm can also appoint... More
